Skip to content
Back to announcement

AnnualReport2023-INAF.pdf

Other Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
Go To English Page

 Nomor Surat                        1180/DIR/VII/2024

 Nama Perusahaan                    Indofarma Tbk.

 Kode Emiten                        INAF

 Lampiran                           2

 Perihal                            Penyampaian Laporan Keberlanjutan

Merujuk pada pelaporan Laporan Tahunan Nomor 1120/DIR/VII/2024.,dengan ini Perseroan menyampaikan laporan
Keberlanjutan tahun 2023 dengan periode tahun buku dari 01 Januari 2023 sampai dengan 31 Desember 2023
Informasi sebagaimana dimaksud di atas telah dimuat pada Situs Web Perseroan di alamat link www.indofarma.id
pada tanggal 15 Juli 2024
Rasio Komposisi:
Jajaran Direksi = 0 Perempuan : 3 Laki-Laki.
Jajaran Level Senior Manajemen = 14 Perempuan : 6 Laki-Laki.

Rata-rata waktu pelatihan Perempuan dan Laki-Laki 19,9 jam.
Daur Ulang Sampah 0 %.


 Demikian untuk diketahui.


 Hormat Kami,
 Indofarma Tbk.




 Warjoko Sumedi

 Corporate Secretary




 Indofarma Tbk.
 Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
 Telepon : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,



 Nama Pengirim                      Warjoko Sumedi

 Jabatan                            Corporate Secretary
 Tanggal dan Waktu                  15-07-2024 15:28

 Lampiran                           1. S 1180 - Penyampaian SR ke OJK.pdf


                                    2. INAF SR 2023.pdf


   Dokumen ini merupakan dokumen resmi Indofarma Tbk. yang tidak memerlukan tanda tangan karena dihasilkan
  secara elektronik oleh sistem pelaporan elektronik. Indofarma Tbk. bertanggung jawab penuh atas informasi yang
                                            tertera didalam dokumen ini.
Page 2
Go To Indonesian Page

 Letter / Announcement No.           1180/DIR/VII/2024

 Issuer Name                         Indofarma Tbk.

 Issuer Code                         INAF

 Attachment                          2

 Subject                             Submission of Continuity Report

Referring to the Annual Report Report Number 1120/DIR/VII/2024., with this The Company hereby submit Continuity
Report 2023 for the period of 01 January 2023 to 31 December 2023 in Indonesia and English
The information referred above has been published on the Company’s website www.indofarma.id at 15 July 2024

Composition Ratio:
Board of Directors = 0 Woman : 3 Man.
Senior Management Level = 14 Woman : 6 Man.

Recycle 0%.


Thus to be informed accordingly.


 Respectfully,
 Indofarma Tbk.




 Warjoko Sumedi

 Corporate Secretary




 Indofarma Tbk.
 Jl. Indofarma No. 1, Cikarang Barat, Bekasi, 17530
 Phone : (021) 8832 3971/75; 8590 8349/50, Fax : (021) 8832 3972/73; 857 4503 ,



 Sender Name                         Warjoko Sumedi

 Function                            Corporate Secretary

 Date and Time                       15-07-2024 15:28

 Attachment                         1. S 1180 - Penyampaian SR ke OJK.pdf


                                    2. INAF SR 2023.pdf


  This is an official document of Indofarma Tbk. that does not require a signature as it was generated electronically
   by the electronic reporting system. Indofarma Tbk. is fully responsible for the information contained within this
                                                      document.

File

File Open PDF
Source IDX
Size0.01 MB
Published15 Jul 2024
Pages2
Characters3,256
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 2 people and organisations named in the text · linked when the evidence is strong

linked person Warjoko Sumedi · Corporate Secretary p.1 ×5
possible org Indofarma Tbk. · Nama Perusahaan p.1 ×9

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 2

↑↓ select ↵ open ⇧↵ see every result